Skip to content

Clinical trials

Phase 1/2 Leukemia, Myelomonocytic, Chronic trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Leukemia, Myelomonocytic, Chronic Phase: Phase 1/2 Clear all

78 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20005
20013
20022
20032
20042
20051
20063
20083
20093
20102
20111
20135
20142
20151
20162
20174
20184
20196
20204
20214
20224
20234
20242
20252
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed38
Recruiting12
Active, not recruiting9
Terminated9
Withdrawn6
Unknown status3
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
M.D. Anderson Cancer Center19
Fred Hutchinson Cancer Center11
National Cancer Institute (NCI)4
Groupe Francophone des Myelodysplasies2
H. Lee Moffitt Cancer Center and Research Institute2
Alliance for Clinical Trials in Oncology1
Aptose Biosciences Inc.1
Arbeitsgemeinschaft medikamentoese Tumortherapie1
Asan Medical Center1
Ascentage Pharma Group Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Leukemia, Myelomonocytic, Chronic78
Myelodysplastic Syndromes50
Leukemia, Myeloid, Acute47
Leukemia22
Myeloproliferative Disorders22
Precursor Cell Lymphoblastic Leukemia-Lymphoma20
Anemia, Refractory, with Excess of Blasts14
Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative14
Lymphoma, Non-Hodgkin14
Hodgkin Disease13

Trials

Showing 76 to 78 of 78. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.